AMA	Apparent molar activity
CANF	C-type atrial natriuretic factor
CAR	Chimeric Antigen Receptor
CT	Computer tomography
DOTA	2,2′,2′′,2′′′-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid
EDQM	European Directorate for the Quality of Medicines & Healthcare
EMA	European Medicines Agency
EOB	End of bombardment
FAP	Fibroblast activation protein
FAPI	Fibroblast activation protein inhibitor
FDA	Food and drug administration
GMP	Good manufacturing practice
GRPR	Gastrin-releasing peptide receptor
HER2	Human epidermal growth factor receptor 2
MA	Molar activity
MRI	Magnetic resonance imaging
NODAGA	1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid
NOTA	1,4,7-Triazacyclononane-1,4,7-triacetic acid
NPR	Natriuretic peptide receptor
PET	Positron emission tomography
PSMA	Prostate specific membrane antigen
RNP	Radionuclidic purity
SAR	3,6,10,13,16,19-hexaazabicyclo(6,6,6)icosane
SPECT	Single-photon emission computed tomography
SPION	Super paramagnetic iron oxide nanoparticles
SSTR	Somatostatin receptor
SUV	Standardized uptake value
TETA	1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid
uPAR	Urokinase-type plasminogen activator receptor